Efficacy and safety of MYL‐1501D versus insulin glargine in people with type 1 diabetes mellitus: Results of the INSTRIDE 3 phase 3 switch study

Thomas C. Blevins; Abhijit Barve; Yaron Raiter; Patrick Aubonnet; Sandeep Athalye; Bin Sun; Rafael Muniz

doi:10.1111/dom.13904

Efficacy and safety of MYL‐1501D versus insulin glargine in people with type 1 diabetes mellitus: Results of the INSTRIDE 3 phase 3 switch study

Diabetes Obesity and Metabolism ◽

10.1111/dom.13904 ◽

2019 ◽

Vol 22 (3) ◽

pp. 365-372 ◽

Cited By ~ 2

Author(s):

Thomas C. Blevins ◽

Abhijit Barve ◽

Yaron Raiter ◽

Patrick Aubonnet ◽

Sandeep Athalye ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 1 Diabetes ◽

Insulin Glargine ◽

Type 1 Diabetes Mellitus ◽

Efficacy And Safety ◽

Phase 3 ◽

Switch Study

Download Full-text

Review for "Efficacy and Safety of MYL‐1501D Versus Insulin Glargine in Patients With Type 1 Diabetes Mellitus: Results of the INSTRIDE 3 Phase 3 Switch Study"

10.1111/dom.13904/v1/review1 ◽

2019 ◽

Keyword(s):

Diabetes Mellitus ◽

Type 1 Diabetes ◽

Insulin Glargine ◽

Type 1 Diabetes Mellitus ◽

Efficacy And Safety ◽

Phase 3 ◽

Switch Study

Download Full-text

Review for "Efficacy and Safety of MYL‐1501D Versus Insulin Glargine in Patients With Type 1 Diabetes Mellitus: Results of the INSTRIDE 3 Phase 3 Switch Study"

10.1111/dom.13904/v1/review3 ◽

2019 ◽

Author(s):

Linsey Gani

Keyword(s):

Diabetes Mellitus ◽

Type 1 Diabetes ◽

Insulin Glargine ◽

Type 1 Diabetes Mellitus ◽

Efficacy And Safety ◽

Phase 3 ◽

Switch Study

Download Full-text

Author response for "Efficacy and Safety of MYL‐1501D Versus Insulin Glargine in Patients With Type 1 Diabetes Mellitus: Results of the INSTRIDE 3 Phase 3 Switch Study"

10.1111/dom.13904/v2/response1 ◽

2019 ◽

Author(s):

Thomas C. Blevins ◽

Abhijit Barve ◽

Yaron Raiter ◽

Patrick Aubonnet ◽

Sandeep Athalye ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 1 Diabetes ◽

Insulin Glargine ◽

Type 1 Diabetes Mellitus ◽

Author Response ◽

Efficacy And Safety ◽

Phase 3 ◽

Switch Study

Download Full-text

Review for "Efficacy and Safety of MYL‐1501D Versus Insulin Glargine in Patients With Type 1 Diabetes Mellitus: Results of the INSTRIDE 3 Phase 3 Switch Study"

10.1111/dom.13904/v2/review1 ◽

2019 ◽

Keyword(s):

Diabetes Mellitus ◽

Type 1 Diabetes ◽

Insulin Glargine ◽

Type 1 Diabetes Mellitus ◽

Efficacy And Safety ◽

Phase 3 ◽

Switch Study

Download Full-text

Decision letter for "Efficacy and Safety of MYL‐1501D Versus Insulin Glargine in Patients With Type 1 Diabetes Mellitus: Results of the INSTRIDE 3 Phase 3 Switch Study"

10.1111/dom.13904/v1/decision1 ◽

2019 ◽

Keyword(s):

Diabetes Mellitus ◽

Type 1 Diabetes ◽

Insulin Glargine ◽

Type 1 Diabetes Mellitus ◽

Efficacy And Safety ◽

Phase 3 ◽

Switch Study

Download Full-text

Decision letter for "Efficacy and Safety of MYL‐1501D Versus Insulin Glargine in Patients With Type 1 Diabetes Mellitus: Results of the INSTRIDE 3 Phase 3 Switch Study"

10.1111/dom.13904/v2/decision1 ◽

2019 ◽

Keyword(s):

Diabetes Mellitus ◽

Type 1 Diabetes ◽

Insulin Glargine ◽

Type 1 Diabetes Mellitus ◽

Efficacy And Safety ◽

Phase 3 ◽

Switch Study

Download Full-text

Review for "Efficacy and Safety of MYL‐1501D Versus Insulin Glargine in Patients With Type 1 Diabetes Mellitus: Results of the INSTRIDE 3 Phase 3 Switch Study"

10.1111/dom.13904/v1/review2 ◽

2019 ◽

Author(s):

Sara Alexanian

Keyword(s):

Diabetes Mellitus ◽

Type 1 Diabetes ◽

Insulin Glargine ◽

Type 1 Diabetes Mellitus ◽

Efficacy And Safety ◽

Phase 3 ◽

Switch Study

Download Full-text

Review for "Efficacy and Safety of MYL‐1501D Versus Insulin Glargine in Patients With Type 1 Diabetes Mellitus: Results of the INSTRIDE 3 Phase 3 Switch Study"

10.1111/dom.13904/v2/review2 ◽

2019 ◽

Author(s):

Fariba Shojaee-Moradie

Keyword(s):

Diabetes Mellitus ◽

Type 1 Diabetes ◽

Insulin Glargine ◽

Type 1 Diabetes Mellitus ◽

Efficacy And Safety ◽

Phase 3 ◽

Switch Study

Download Full-text

Review for "Efficacy and Safety of MYL‐1501D Versus Insulin Glargine in Patients With Type 1 Diabetes Mellitus: Results of the INSTRIDE 3 Phase 3 Switch Study"

10.1111/dom.13904/v1/review5 ◽

2019 ◽

Keyword(s):

Diabetes Mellitus ◽

Type 1 Diabetes ◽

Insulin Glargine ◽

Type 1 Diabetes Mellitus ◽

Efficacy And Safety ◽

Phase 3 ◽

Switch Study

Download Full-text

Review for "Efficacy and Safety of MYL‐1501D Versus Insulin Glargine in Patients With Type 1 Diabetes Mellitus: Results of the INSTRIDE 3 Phase 3 Switch Study"

10.1111/dom.13904/v1/review4 ◽

2019 ◽

Keyword(s):

Diabetes Mellitus ◽

Type 1 Diabetes ◽

Insulin Glargine ◽

Type 1 Diabetes Mellitus ◽

Efficacy And Safety ◽

Phase 3 ◽

Switch Study

Download Full-text